Kyorin Pharmaceutical. (KYRNF) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
0.04
0.12
0.19
0.27

Details

Expected EPS
N/A
Actual EPS
0.04480308
Surprise EPS
0.04
Surprise Percent
+∞%

Description

Kyorin Pharmaceutical. (KYRNF) has reported earnings of 0.04480308 per share for Q4 2024.

0 Comments

Share your thoughts